RACE ONCOLOGY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.65 AUD | +6.45% |
|
+38.66% | +96.43% |
| 03-26 | Race Oncology Obtains Certificate of Analysis for RC220; Shares Up Almost 6% | MT |
| 03-18 | Race Oncology Limited(ASX:RAC) dropped from S&P/ASX All Ordinaries Index | CI |
Chart calendar Race Oncology Limited
980c9cf2e4b1b85b7513ffe9b.2FoKdELRifaen_lnILf7Ev30Lk-2PUmYS-DXDMfJhzA.lz1PPADm48HQ15Qfd8Kfa5DNeifACT2sD5bvbpav5FiKEWwWBpzElMT1ig~653ff2aafee6201252e64320e0949173
Upcoming events on Race Oncology Limited
Past events on Race Oncology Limited
| 2024-02-27 16:44 | Q2 2024 Earnings Release |
| 2024-01-29 21:21 | December 2023 Sales and Revenue Release - Activities Report |
| 2023-12-08 | American Society of Hematology Meeting |
| 2023-11-26 20:00 | Annual General Meeting |
| 2023-11-22 19:30 | Investor Meeting |
| 2023-11-22 19:30 | Business Update Call |
| 2023-10-22 18:24 | September 2023 Sales and Revenue Release - Activities Report |
| 2023-08-30 00:08 | Q4 2023 Earnings Release |
| 2023-08-17 04:30 | Investor Meeting |
| 2023-08-15 00:00 | Investor Meeting |
| 2023-08-10 22:00 | Investor Meeting |
| 2023-08-09 05:30 | Investor Meeting |
| 2023-07-30 18:46 | June 2023 Sales and Revenue Release - Activities Report |
| 2023-04-27 19:40 | March 2023 Sales and Revenue Release - Activities Report |
| 2023-02-27 00:31 | Q2 2023 Earnings Release |
| 2023-02-20 18:30 | Shareholders Meeting |
| 2023-01-30 19:07 | December 2022 Sales and Revenue Release - Activities Report |
| 2022-11-23 20:00 | Annual General Meeting |
| 2022-10-26 | September 2022 Sales and Revenue Release - Activities Report |
| 2022-10-20 03:00 | Investor Meeting |
Annual results
| Fiscal Period | Giugno | 2024 |
|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 0,00 |
|
EBITDA Million AUD | Released Forecast Spread | -11,6 |
|
EBIT Million AUD | Released Forecast Spread | -11,9 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -11,7 |
|
Net income Million AUD | Released Forecast Spread | -11,7 |
|
EPS AUD | Released Forecast Spread | -0,07 |
| Announcement Date | - |
| 2024-05-14 | CELCUITY INC.: Q1 2024 Earnings Release |
| 2024-05-15 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 09:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-17 07:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-07-23 | VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | BIOCON LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-25 01:00 | ARGENX SE: Q2 2024 Earnings Release |
| 2024-07-29 | RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-29 | NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-29 | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Race Oncology Limited
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RAC Stock
- Calendar Race Oncology Limited